121 related articles for article (PubMed ID: 38199503)
1. Could we use PD-1 and PD-L1 expression on lymphocytes and monocytes as predictive markers for prognosis of acute biliary pancreatitis?
Idiz UO; Aru B; Kaya C; Peker KD; Tatar C; Guler M; Tunay A; Demirel GY; Gurol AO
Immunol Lett; 2024 Feb; 265():37-43. PubMed ID: 38199503
[TBL] [Abstract][Full Text] [Related]
2. Monocyte programmed death ligand-1 expression is an early marker for predicting infectious complications in acute pancreatitis.
Pan T; Zhou T; Li L; Liu Z; Chen Y; Mao E; Li M; Qu H; Liu J
Crit Care; 2017 Jul; 21(1):186. PubMed ID: 28705256
[TBL] [Abstract][Full Text] [Related]
3. The PD-1 with PD-L1 Axis Is Pertinent with the Immune Modulation of Atrial Fibrillation by Regulating T Cell Excitation and Promoting the Secretion of Inflammatory Factors.
Chang G; Chen Y; Liu Z; Wang Y; Ge W; Kang Y; Guo S
J Immunol Res; 2022; 2022():3647817. PubMed ID: 35600045
[TBL] [Abstract][Full Text] [Related]
4. Expanded CD14
Zhang R; Shi J; Zhang R; Ni J; Habtezion A; Wang X; Hu G; Xue J
J Immunol; 2019 May; 202(9):2578-2584. PubMed ID: 30894427
[TBL] [Abstract][Full Text] [Related]
5. Immune Checkpoint Inhibitor-Induced Thyroiditis Is Associated with Increased Intrathyroidal T Lymphocyte Subpopulations.
Kotwal A; Gustafson MP; Bornschlegl S; Kottschade L; Delivanis DA; Dietz AB; Gandhi M; Ryder M
Thyroid; 2020 Oct; 30(10):1440-1450. PubMed ID: 32323619
[No Abstract] [Full Text] [Related]
6. Immunopathogenesis of dilated cardiomyopathy. Evidence for the role of TH2-type CD4+T lymphocytes and association with myocardial HLA-DR expression.
Kuethe F; Braun RK; Foerster M; Schlenker Y; Sigusch HH; Kroegel C; Figulla HR
J Clin Immunol; 2006 Jan; 26(1):33-9. PubMed ID: 16418801
[TBL] [Abstract][Full Text] [Related]
7. Immunological findings in acute and chronic pancreatitis.
Bhatnagar A; Wig JD; Majumdar S
ANZ J Surg; 2003; 73(1-2):59-64. PubMed ID: 12534743
[TBL] [Abstract][Full Text] [Related]
8. Human CD8
Machicote A; Belén S; Baz P; Billordo LA; Fainboim L
Front Immunol; 2018; 9():2788. PubMed ID: 30555473
[TBL] [Abstract][Full Text] [Related]
9. [Effect of dendritic cells on immune function regulated by programmed cell death-1/programmed cell death-ligand 1 in sepsis].
Wang Z; Xie Z; Zhao Y; Bu T; Yu A; Wang S
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Sep; 33(9):1032-1039. PubMed ID: 34839857
[TBL] [Abstract][Full Text] [Related]
10. Programmed Cell Death Ligand (PD-L)-1 Contributes to the Regulation of CD4
de Freitas E Silva R; Gálvez RI; Pereira VRA; de Brito MEF; Choy SL; Lotter H; Bosurgi L; Jacobs T
Front Immunol; 2020; 11():574491. PubMed ID: 33193363
[TBL] [Abstract][Full Text] [Related]
11. IL-10 induces the development of immunosuppressive CD14(+)HLA-DR(low/-) monocytes in B-cell non-Hodgkin lymphoma.
Xiu B; Lin Y; Grote DM; Ziesmer SC; Gustafson MP; Maas ML; Zhang Z; Dietz AB; Porrata LF; Novak AJ; Liang AB; Yang ZZ; Ansell SM
Blood Cancer J; 2015 Jul; 5(7):e328. PubMed ID: 26230952
[TBL] [Abstract][Full Text] [Related]
12. Systemic Immunological changes in patients with distinct clinical outcomes during Mycobacterium tuberculosis infection.
Morais-Papini TF; Coelho-Dos-Reis JGA; Wendling APB; do Vale Antonelli LR; Wowk PF; Bonato VLD; Augusto VM; Elói-Santos S; Martins-Filho OA; Carneiro CM; Teixeira-Carvalho A
Immunobiology; 2017 Nov; 222(11):1014-1024. PubMed ID: 28619539
[TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma increases monocyte PD-L1 but does not diminish T-cell activation.
Galbraith NJ; Walker SP; Gardner SA; Bishop C; Galandiuk S; Polk HC
Cell Immunol; 2020 Nov; 357():104197. PubMed ID: 32891037
[TBL] [Abstract][Full Text] [Related]
14. Circulating HLA-DR+CD4+ effector memory T cells resistant to CCR5 and PD-L1 mediated suppression compromise regulatory T cell function in tuberculosis.
Ahmed A; Adiga V; Nayak S; Uday Kumar JAJ; Dhar C; Sahoo PN; Sundararaj BK; Souza GD; Vyakarnam A
PLoS Pathog; 2018 Sep; 14(9):e1007289. PubMed ID: 30231065
[TBL] [Abstract][Full Text] [Related]
15. HLA-DR Expression Level in CD8
Wang Y; Luo Y; Tang G; Ouyang R; Zhang M; Jiang Y; Wang T; Zhang X; Yin B; Huang J; Wei W; Huang M; Wang F; Wu S; Hou H
Front Immunol; 2021; 12():753290. PubMed ID: 34804038
[TBL] [Abstract][Full Text] [Related]
16. PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients.
Costa F; Vescovini R; Marchica V; Storti P; Notarfranchi L; Dalla Palma B; Toscani D; Burroughs-Garcia J; Catarozzo MT; Sammarelli G; Giuliani N
Front Immunol; 2020; 11():613007. PubMed ID: 33488620
[TBL] [Abstract][Full Text] [Related]
17. Redistribution of Monocyte Subsets in Obstructive Sleep Apnea Syndrome Patients Leads to an Imbalanced PD-1/PD-L1 Cross-Talk with CD4/CD8 T Cells.
Polasky C; Steffen A; Loyal K; Lange C; Bruchhage KL; Pries R
J Immunol; 2021 Jan; 206(1):51-58. PubMed ID: 33268482
[TBL] [Abstract][Full Text] [Related]
18. Immune Profile Analysis in Peripheral Blood and Tumor in Patients with Malignant Melanoma.
Saito R; Sawada Y; Nakamura M
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669410
[TBL] [Abstract][Full Text] [Related]
19. Differential impact of PD-1 and/or interleukin-10 blockade on HIV-1-specific CD4 T cell and antigen-presenting cell functions.
Porichis F; Hart MG; Zupkosky J; Barblu L; Kwon DS; McMullen A; Brennan T; Ahmed R; Freeman GJ; Kavanagh DG; Kaufmann DE
J Virol; 2014 Mar; 88(5):2508-18. PubMed ID: 24352453
[TBL] [Abstract][Full Text] [Related]
20. Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti-PD-1 Therapies in Metastatic Melanoma.
Johnson DB; Bordeaux J; Kim JY; Vaupel C; Rimm DL; Ho TH; Joseph RW; Daud AI; Conry RM; Gaughan EM; Hernandez-Aya LF; Dimou A; Funchain P; Smithy J; Witte JS; McKee SB; Ko J; Wrangle JM; Dabbas B; Tangri S; Lameh J; Hall J; Markowitz J; Balko JM; Dakappagari N
Clin Cancer Res; 2018 Nov; 24(21):5250-5260. PubMed ID: 30021908
[No Abstract] [Full Text] [Related]
[Next] [New Search]
